Enabling Consideration Of Packaging In The Early Stage Of Combination Product Development
By Liang Fang, Ranjana Singh, Cathy Zhao, West Pharmaceutical Services, Inc.
Since it is very costly to rework a drug formulation due to an incompatibility with its packaging, combination product regulation drives the early understanding of drug/container compatibility for the intended use. This poster provides two case studies to show how West assess drug/packaging interactions and demonstrates the importance and feasibility of taking the container system into consideration in the early drug development stage.
VIEW THE POSTER! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.
Subscribe to Biosimilar Development X
Subscribe to Biosimilar Development